Baring Private Equity Asia (BPEA), through its affiliated funds, has agreed to acquire Israel-based Lumenis in a deal that values the medtech company at over $1 billion, according to an official statement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in